4//SEC Filing
Evolent Health, Inc. 4
Accession 0001232583-17-000005
$EVHCIK 0001628908operating
Filed
May 2, 8:00 PM ET
Accepted
May 3, 5:04 PM ET
Size
9.1 KB
Accession
0001232583-17-000005
Insider Transaction Report
Form 4
WIGGINTON STEVE
Chief Development Officer
Transactions
- Exercise/Conversion
Class A Common Stock
2017-05-01$3.84/sh+6,000$23,040→ 364,704 total - Sale
Class A Common Stock
2017-05-01$23.10/sh−6,000$138,600→ 358,704 total - Exercise/Conversion
Class A Common Stock Option (right to buy)
2017-05-01−6,000→ 417,680 totalExercise: $3.84Exp: 2024-04-01→ Class A Common Stock (6,000 underlying)
Footnotes (3)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 12, 2016.
- [F2]The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $22.90-$23.35, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The Class A Common Stock Options exercised began vesting at a rate of 25% annually beginning October 1, 2014.
Documents
Issuer
Evolent Health, Inc.
CIK 0001628908
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001628908
Filing Metadata
- Form type
- 4
- Filed
- May 2, 8:00 PM ET
- Accepted
- May 3, 5:04 PM ET
- Size
- 9.1 KB